메뉴 건너뛰기




Volumn 20, Issue 4, 2002, Pages 239-243

Adjuvant chemotherapy for stage II nonseminomatous germ-cell tumors

Author keywords

Adjuvant therapy; Nonseminomatous germ cell tumors; Review; Stage II

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; VINBLASTINE;

EID: 0036864942     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: 10.1053/suro.2002.36975     Document Type: Review
Times cited : (4)

References (33)
  • 2
    • 0018240239 scopus 로고
    • Germ cell tumors(II): VAB II in metastatic testicular cancer
    • Cheng E, Cvitkovic E, Wittes RE, et al: Germ cell tumors(II): VAB II in metastatic testicular cancer. Cancer 42:2162-2168, 1978
    • (1978) Cancer , vol.42 , pp. 2162-2168
    • Cheng, E.1    Cvitkovic, E.2    Wittes, R.E.3
  • 3
    • 0017672542 scopus 로고
    • Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer
    • Einhorn LH, Donohue J: Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293-298, 1977
    • (1977) Ann Intern Med , vol.87 , pp. 293-298
    • Einhorn, L.H.1    Donohue, J.2
  • 4
    • 0019418649 scopus 로고
    • VAB-3 combination chemotherapy of metastatic testicular cancer
    • Reynolds TF, Vugrin D, Cvitkovic E, et al: VAB-3 combination chemotherapy of metastatic testicular cancer. Cancer 48:888-898, 1981
    • (1981) Cancer , vol.48 , pp. 888-898
    • Reynolds, T.F.1    Vugrin, D.2    Cvitkovic, E.3
  • 5
    • 0019513021 scopus 로고
    • Adjuvant chemotherapy combination of vinblastine, actinomycin D, bleomycin, and chlorambucil following retroperitoneal lymph node dissection for stage II testis tumor
    • Vugrin D, Whitmore WF, Cvitkovic E, et al: Adjuvant chemotherapy combination of vinblastine, actinomycin D, bleomycin, and chlorambucil following retroperitoneal lymph node dissection for stage II testis tumor. Cancer 47:840-844, 1981
    • (1981) Cancer , vol.47 , pp. 840-844
    • Vugrin, D.1    Whitmore, W.F.2    Cvitkovic, E.3
  • 6
    • 0027513298 scopus 로고
    • Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multi-institutional study
    • Bajorin DF, Sarosdy MF, Pfister DG, et al: Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multi-institutional study. J Clin Oncol 11:598-606, 1993
    • (1993) J Clin Oncol , vol.11 , pp. 598-606
    • Bajorin, D.F.1    Sarosdy, M.F.2    Pfister, D.G.3
  • 7
    • 0023684525 scopus 로고
    • A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors
    • Bosl GJ, Geller NL, Bajorin D, et al: A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. J Clin Oncol 6:1231-1238, 1988
    • (1988) J Clin Oncol , vol.6 , pp. 1231-1238
    • Bosl, G.J.1    Geller, N.L.2    Bajorin, D.3
  • 8
    • 0024555713 scopus 로고
    • Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group protocol
    • Einhorn LH, Williams SD, Lochrer PJ, et al: Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group protocol. J Clin Oncol 7:387-391, 1989
    • (1989) J Clin Oncol , vol.7 , pp. 387-391
    • Einhorn, L.H.1    Williams, S.D.2    Lochrer, P.J.3
  • 9
    • 0028860147 scopus 로고
    • Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Cooperative Oncology Group trial
    • Loehrer PJ Sr, Johnson D, Elson P, et al: Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Cooperative Oncology Group trial. J Clin Oncol 13:470-476, 1995
    • (1995) J Clin Oncol , vol.13 , pp. 470-476
    • Loehrer P.J., Sr.1    Johnson, D.2    Elson, P.3
  • 10
    • 0030757467 scopus 로고    scopus 로고
    • Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin
    • Xiao H, Mazumdar M, Bajorin DF, et al: Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin. J Clin Oncol 15:2553-2558, 1997
    • (1997) J Clin Oncol , vol.15 , pp. 2553-2558
    • Xiao, H.1    Mazumdar, M.2    Bajorin, D.F.3
  • 11
    • 0018258188 scopus 로고
    • Improved management of nonseminomatous testis tumors
    • Donohue JP, Einhorn LH, Perez JM: Improved management of nonseminomatous testis tumors. Cancer 42:2903-2908, 1978
    • (1978) Cancer , vol.42 , pp. 2903-2908
    • Donohue, J.P.1    Einhorn, L.H.2    Perez, J.M.3
  • 12
    • 0031892019 scopus 로고    scopus 로고
    • Clinical stage I nonseminoma: Surgery versus surveillance
    • Foster RS, Roth BJ: Clinical stage I nonseminoma: Surgery versus surveillance. Semin Oncol 25:145-153, 1998
    • (1998) Semin Oncol , vol.25 , pp. 145-153
    • Foster, R.S.1    Roth, B.J.2
  • 13
    • 0017143127 scopus 로고
    • Prognosis for pathologic stage I non-seminomatous germ cell tumors of the testis managed by retroperitoneal lymphadenectomy
    • Johnson DE, Bracken RB, Blight EM: Prognosis for pathologic stage I non-seminomatous germ cell tumors of the testis managed by retroperitoneal lymphadenectomy. J Urol 116:63-65, 1976
    • (1976) J Urol , vol.116 , pp. 63-65
    • Johnson, D.E.1    Bracken, R.B.2    Blight, E.M.3
  • 14
    • 0020567662 scopus 로고
    • Selected experience with surgery and combination chemotherapy in the treatment of nonseminomatous testis tumors
    • Bredael JJ, Vugrin D, Whitmore WF Jr: Selected experience with surgery and combination chemotherapy in the treatment of nonseminomatous testis tumors. J Urol 129:985-988, 1983
    • (1983) J Urol , vol.129 , pp. 985-988
    • Bredael, J.J.1    Vugrin, D.2    Whitmore W.F., Jr.3
  • 15
    • 0018875735 scopus 로고
    • Testicular cancer: Risk factors and the role of adjuvant chemotherapy
    • Jacobs EM, Muggia FM: Testicular cancer: Risk factors and the role of adjuvant chemotherapy. Cancer 45:1782-1790, 1980
    • (1980) Cancer , vol.45 , pp. 1782-1790
    • Jacobs, E.M.1    Muggia, F.M.2
  • 16
    • 0021084037 scopus 로고
    • Stage II nonseminomatous testicular cancer: A 10-year experience
    • Vogelzang NJ, Fraley EE, Lange PH, et al: Stage II nonseminomatous testicular cancer: A 10-year experience. J Clin Oncol 1:171-178, 1983
    • (1983) J Clin Oncol , vol.1 , pp. 171-178
    • Vogelzang, N.J.1    Fraley, E.E.2    Lange, P.H.3
  • 17
    • 0019433694 scopus 로고
    • Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancer
    • Vugrin D, Whitmore W, Cvitkovic E, et al: Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancer. Cancer 48:233-237, 1981
    • (1981) Cancer , vol.48 , pp. 233-237
    • Vugrin, D.1    Whitmore, W.2    Cvitkovic, E.3
  • 18
    • 0019464095 scopus 로고
    • VAB-4 combination chemotherapy in the treatment of metastatic testis tumors
    • Vugrin D, Cvitkovic E, Whitmore WF Jr, et al: VAB-4 combination chemotherapy in the treatment of metastatic testis tumors. Cancer 47:833-839, 1981
    • (1981) Cancer , vol.47 , pp. 833-839
    • Vugrin, D.1    Cvitkovic, E.2    Whitmore W.F., Jr.3
  • 19
    • 0020659795 scopus 로고
    • VAB-6 combination chemotherapy in resected stage II-B testis cancer
    • Vugrin D, Whitmore WF Jr, Herr HW, et al: VAB-6 combination chemotherapy in resected stage II-B testis cancer. Cancer 51:5-8, 1983
    • (1983) Cancer , vol.51 , pp. 5-8
    • Vugrin, D.1    Whitmore W.F., Jr.2    Herr, H.W.3
  • 20
    • 0026318099 scopus 로고
    • Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor
    • Weissbach L, Hartlapp JH: Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor. J Urol 146:1295-1298, 1991
    • (1991) J Urol , vol.146 , pp. 1295-1298
    • Weissbach, L.1    Hartlapp, J.H.2
  • 21
    • 0025902314 scopus 로고
    • Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?
    • Richie JP, Kantoff PW: Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer? J Clin Oncol 9:1393-1396, 1991
    • (1991) J Clin Oncol , vol.9 , pp. 1393-1396
    • Richie, J.P.1    Kantoff, P.W.2
  • 22
    • 0018852516 scopus 로고
    • Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: Current perspective
    • Skinner DG, Scardino PT: Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: Current perspective. J Urol 123:378-382, 1980
    • (1980) J Urol , vol.123 , pp. 378-382
    • Skinner, D.G.1    Scardino, P.T.2
  • 23
    • 0023243140 scopus 로고
    • Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer
    • Williams SD, Stablein DM, Einhorn LH, et al: Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 317:1433-1438, 1987
    • (1987) N Engl J Med , vol.317 , pp. 1433-1438
    • Williams, S.D.1    Stablein, D.M.2    Einhorn, L.H.3
  • 24
    • 0020470226 scopus 로고
    • Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cisplatinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer
    • Vugrin D, Whitmore WF Jr, Herr H, et al: Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cisplatinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer. J Urol 128:715-717, 1982
    • (1982) J Urol , vol.128 , pp. 715-717
    • Vugrin, D.1    Whitmore W.F., Jr.2    Herr, H.3
  • 25
    • 0023258435 scopus 로고
    • Adjuvant chemotherapy in nonseminomatous testicular tumour stage II
    • Hartlapp JH, Weissbach L, Bussar-Maatz R: Adjuvant chemotherapy in nonseminomatous testicular tumour stage II. Int J Androl 10:277-284, 1987
    • (1987) Int J Androl , vol.10 , pp. 277-284
    • Hartlapp, J.H.1    Weissbach, L.2    Bussar-Maatz, R.3
  • 26
    • 0021142733 scopus 로고
    • No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis
    • Pizzocaro G, Monfardini S: No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis. J Urol 131:677-680, 1984
    • (1984) J Urol , vol.131 , pp. 677-680
    • Pizzocaro, G.1    Monfardini, S.2
  • 27
    • 0021863878 scopus 로고
    • Surgical treatment of patients with stages I and II nonseminomatous testicular cancer
    • Fraley EE, Narayan P, Vogelzang NJ, et al: Surgical treatment of patients with stages I and II nonseminomatous testicular cancer. J Urol 134:70-73, 1985
    • (1985) J Urol , vol.134 , pp. 70-73
    • Fraley, E.E.1    Narayan, P.2    Vogelzang, N.J.3
  • 28
    • 0026057869 scopus 로고
    • Two-drug therapy in patients with metastatic germ cell tumors
    • Bajorin DF, Geller NL, Weisen SF, et al: Two-drug therapy in patients with metastatic germ cell tumors. Cancer 67:28-32, 1991
    • (1991) Cancer , vol.67 , pp. 28-32
    • Bajorin, D.F.1    Geller, N.L.2    Weisen, S.F.3
  • 29
    • 0023195303 scopus 로고
    • Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide
    • Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316:1435-1440, 1987
    • (1987) N Engl J Med , vol.316 , pp. 1435-1440
    • Williams, S.D.1    Birch, R.2    Einhorn, L.H.3
  • 30
    • 0028783356 scopus 로고
    • Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors
    • Motzer RJ, Sheinfeld J, Mazumdar M, et al: Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors. J Clin Oncol 13:2700-2704, 1995
    • (1995) J Clin Oncol , vol.13 , pp. 2700-2704
    • Motzer, R.J.1    Sheinfeld, J.2    Mazumdar, M.3
  • 31
    • 0021347523 scopus 로고
    • Adjuvant chemotherapy in resected stage-II nonseminomatous germ cell tumors of testis. In which cases is it necessary?
    • Pizzocaro G, Piva L, Salvioni R, et al: Adjuvant chemotherapy in resected stage-II nonseminomatous germ cell tumors of testis. In which cases is it necessary? Eur Urol 10:151-158, 1984
    • (1984) Eur Urol , vol.10 , pp. 151-158
    • Pizzocaro, G.1    Piva, L.2    Salvioni, R.3
  • 32
    • 0034012705 scopus 로고    scopus 로고
    • Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. The Indiana University experience
    • Behnia M, Foster R, Einhorn LH, et al: Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. The Indiana University experience. Eur J Cancer 36:472-475, 2000
    • (2000) Eur J Cancer , vol.36 , pp. 472-475
    • Behnia, M.1    Foster, R.2    Einhorn, L.H.3
  • 33
    • 0035300616 scopus 로고    scopus 로고
    • Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: Pattern and prognostic factors for relapse
    • Rabbani F, Sheinfeld J, Farivar-Mohseni H, et al: Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: Pattern and prognostic factors for relapse. J Clin Oncol 19:2020-2025, 2001
    • (2001) J Clin Oncol , vol.19 , pp. 2020-2025
    • Rabbani, F.1    Sheinfeld, J.2    Farivar-Mohseni, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.